Cite
HARVARD Citation
Wallace, D. et al. (n.d.). OP0232 Sustained safety and efficacy over 10 years with belimumab (BEL) plus standard systemic lupus erythematosus (SLE) therapy (SOC) in patients with SLE. Annals of the rheumatic diseases. pp. 150-151. [Online].